Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Ql2 - Health Utility of Patients With Type 2 Diabetes and Various Single and Multiple Complications in China: A Nationwide Survey

Value in Health

English

Php341 - Are There Enough Regulations to Combat the Poor Quality Povidone-Iodine in Egypt

English

Psy72 - Cost of Illness Analysis: Economic Burden in Direct Costs of Obesity-Related Co-Morbidities – Stroke, Myocardial Infarction, Type 2 Diabetes - In Russia

English

Pdb126 - Factors Influencing Food Choices of People With Type 2 Diabetes: A Q Methodology Study

English

Psy184 - Hta and Reimbursement Considerations for Rare Diseases in European Markets: What Are the Implications for Manufacturers?s?

English

Pdb76 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Liraglutide Based on Cardiovascular Outcome Trials

English

Access to Non Communicable Disease Medicines in India: A Comparative Analysis of State Level Public Procurement Data

English

Prm124 - Modelling Likely Cardiovascular Disease Mortality With Pcsk9 Inhibitors Using a Synthetic Population

English

Psy109 - What Interpretation of Icers in Orphan Diseases? A French Example

English

Php13 - Usage of Dietary Supplements by Gym Visiting Athletes – Effects, Awareness and Consciousness

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Ql2 - Health Utility of Patients With Type 2 Diabetes and Various Single and Multiple Complications in China: A Nationwide Survey

Php341 - Are There Enough Regulations to Combat the Poor Quality Povidone-Iodine in Egypt

Psy72 - Cost of Illness Analysis: Economic Burden in Direct Costs of Obesity-Related Co-Morbidities – Stroke, Myocardial Infarction, Type 2 Diabetes - In Russia

Pdb126 - Factors Influencing Food Choices of People With Type 2 Diabetes: A Q Methodology Study

Psy184 - Hta and Reimbursement Considerations for Rare Diseases in European Markets: What Are the Implications for Manufacturers?s?

Pdb76 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Liraglutide Based on Cardiovascular Outcome Trials

Access to Non Communicable Disease Medicines in India: A Comparative Analysis of State Level Public Procurement Data

Prm124 - Modelling Likely Cardiovascular Disease Mortality With Pcsk9 Inhibitors Using a Synthetic Population

Psy109 - What Interpretation of Icers in Orphan Diseases? A French Example

Php13 - Usage of Dietary Supplements by Gym Visiting Athletes – Effects, Awareness and Consciousness